Integrative Diagnosis for SCD and Other RADs

Recruiting now

Conditions studied: Sickle Cell Disease, Thalassaemia, Congenital Dyserythropoietic Anemia (CDA), Enzyme Disorder; Anemia, Spherocytosis, Hereditary, Stomatocytosis, Hemoglobin Disorder, Anemia Due to Membrane Defect, Rare Anemia Disorders

In brief

INTEGRA aims at enabling personalized medicine for RHADs patients by the establishment of an integrative diagnostic approach based on deep phenotypic and genetic characterization through combining new generation methodologies.

Key facts

Study ID
NCT07206095
Run by
Hospital Universitari Vall d'Hebron Research Institute
People needed
200
Starts
2020-11-13
Expected to finish
2028-05-01
Last updated by the study team
2025-10-03

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.